Advances in Bacillus Calmette-Guerin
10.13200/j.cnki.cjb.000083
- VernacularTitle:卡介苗的研究进展
- Author:
CAO Hui
- Publication Type:Journal Article
- Keywords:
Tuberculosis(TB);
Bacillus Calmette-Guerin(BCG);
Vaccine
- From:
Chinese Journal of Biologicals
2023;36(12):1530-1537
- CountryChina
- Language:Chinese
-
Abstract:
Tuberculosis(TB) is a chronic and debilitating infectious disease caused by Mycobacterium tuberculosis(Mtb). It is a significant health concern that poses a serious threat to human well-being. Bacillus Calmette-Guerin(BCG)is the only approved vaccine for the prevention of TB. BCG is made from attenuated bovine Mtb and is highly effective in preventing tuberculous meningitis and granulomatous TB,which are particularly lethal in infants. However,BCG provides limited protection in both children and adults,and this protective effect decreases over time. Currently,there are ongoing improvements being made to BCG,which involve modifications in immunization routes and procedures. Additionally,researchers are working on the development of new TB vaccines. BCG is primarily used for the prevention of TB and the treatment of bladder cancer,although it also has other indications. This paper reviewed the recent research progress of BCG,focusing on its development history,improvements,and indications.
